Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Pain, Postoperative 3Prostatic Neoplasms 2Pain 2Leiomyoma 2Hot Flashes 2Breast Neoplasms 2Uterine Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Malignant Neoplasms of Female Genital Organs 1Lung Neoplasms 1Ileus 1Agnosia 1

Interventions

Paclitaxel 4seribantumab 1pembrolizumab 1gedatolisib 1fluciclovine F-18 1TP protocol 1Standard of Care 1Oxaliplatin 1Music Therapy 1Leucovorin 1Letrozole 1Immunoglobulin G 1Imatinib Mesylate 1Imagery, Psychotherapy 1Hysterectomy 1Fluorouracil 1Device Removal 1Cisplatin 1Celecoxib 1Carboplatin 1Bupivacaine 1Bevacizumab 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Uterine Neoplasms × Bupivacaine × Clear all
NCT04849858 2024-08-23

Pilot Study of Liposomal Bupivacaine Redosing in Patients Undergoing Major Gynecologic Procedures

University of California, Irvine

Phase 3 Terminated
13 enrolled
Gynecologic

Leiomyoma, Ovarian Neoplasms, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡